Novo Nordisk (NYSE: NVO) stock slipped 1.7% through 12:10 a.m. ET Monday on a pair of news items with which investors seem ...

Shares of Eli Lilly & Co. LLY rallied 3.26% to $864.90 Monday, on what proved to be an all-around great trading session for ...

Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Berenberg Bank analyst Kerry Holford maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on March 21 and set a price target ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Eli Lilly (NYSE: LLY) stock defied today's market ... It's as simple as that -- and good enough for a 2.6% stock price bump. Ever feel like you missed the boat in buying the most successful ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Eli Lilly is buying a new drug and lowering prices ... It's as simple as that -- and good enough for a 2.6% stock price bump. Rich Smith has no position in any of the stocks mentioned.

Eli Lilly stock has advanced more than 200% over ... Lilly's revenue climb in the double digits in recent quarters and the stock price to take off. The shares have advanced more than 200% over ...